多西环素涂层硅胶乳房假体减少急性手术部位感染与炎症
该研究将多西环素涂覆于硅胶乳房假体,通过体外实验和小鼠模型评估其抗生物膜、抗感染及抗炎效果。结果显示涂层假体无成纤维细胞毒性,体外抑制MRSA和铜绿假单胞菌生物膜形成,小鼠体内显著减少细菌定植和炎症反应。
要点
- 多西环素涂层硅胶假体可抑制MRSA和铜绿假单胞菌生物膜形成及细菌黏附。
- 小鼠模型中涂层假体显著减少3天和7天的细菌定植及炎症细胞浸润。
- 涂层对成纤维细胞无毒性,24小时可测得多西环素释放。
核心结论
- 多西环素涂层硅胶乳房假体可显著减少生物膜形成、手术部位感染和炎症。
研究设计与样本
- 体外研究表征涂层(傅里叶红外光谱、洗脱数据、毒性试验,n=4)。
- 体外及小鼠模型(n=8)评估涂层假体对MRSA和铜绿假单胞菌的抗菌性能,观察3天和7天。
主要发现
- 涂层假体出现颜色变化、质量增加,傅里叶红外光谱符合多西环素涂层特征。
- 涂层对成纤维细胞无毒性,体外抑制MRSA和铜绿假单胞菌生物膜形成及细菌黏附,24小时可测得多西环素浓度。
- 小鼠模型中,涂层假体组较对照组、腹腔多西环素治疗组及庆大霉素/头孢唑林/杆菌肽冲洗组,在3天和7天时MRSA和铜绿假单胞菌定植显著减少。
- 涂层假体组小鼠炎症细胞因子和炎症细胞浸润减少。
临床怎么用
- 该涂层技术可能为假体乳房再造中预防手术部位感染提供新策略,但需进一步研究长期影响。
局限性
- 需进一步研究评估长期影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical-site infection after implant-based breast reconstruction remains a leading cause of morbidity. Doxycycline is an antibiotic used to treat soft-tissue infections. The authors hypothesize that doxycycline-coated breast implants will significantly reduce biofilm formation, surgical-site infection, and inflammation after bacterial infection. METHODS: Pieces of silicone breast implants were coated in doxycycline. In vitro studies to characterize the coating include Fourier transmission infrared spectroscopy, elution data, and toxicity assays (n = 4). To evaluate antimicrobial properties, coated implants were studied after methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa inoculation in vitro and in a mouse model at 3 and 7 days (n = 8). Studies included bacterial quantification, cytokine profiles, and histology. RESULTS: Coated silicone breast implants demonstrated a color change, increased mass, and Fourier transmission infrared spectroscopy consistent with a doxycycline coating. Coated implants were nontoxic to fibroblasts and inhibited biofilm formation and bacterial adherence after MRSA and P. aeruginosa incubation in vitro, and measurable doxycycline concentrations at 24 hours were seen. In a mouse model, a significant reduction of MRSA and P. aeruginosa bacterial colonization after 3 and 7 days in the doxycycline-coated implant mice was demonstrated when compared to the control mice, control mice treated with intraperitoneal doxycycline, and control mice treated with a gentamicin/cefazolin/bacitracin wash. Decreased inflammatory cytokines and inflammatory cell infiltration were demonstrated in the doxycycline-coated mice. CONCLUSIONS: A method to coat silicone implants with doxycycline was developed. The authors' doxycycline-coated silicone implants significantly reduced biofilm formation, surgical-site infections, and inflammation. Further studies are needed to evaluate the long-term implications.
引用
- Baker JE, Seitz AP, Boudreau RM, et al. Doxycycline-Coated Silicone Breast Implants Reduce Acute Surgical-Site Infection and Inflammation. Plast Reconstr Surg. 2020. PMID: 33141530. doi:10.1097/PRS.0000000000007277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。